Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), has appointed Khandan Baradaran, PhD, as Senior Vice President of Regulatory and Quality.   Baradaran brings nearly two decades of experience in manufacturing and regulatory review of gene therapy products, including regulatory and chemistry, manufacturing, and controls (CMC) experience.   “Khandan’s experie...